Retinopathy References

Disease Prevention and Treatment, 5th edition

The references on this page correspond with the print version of Disease Prevention and Treatment, 5th edition. Since we continuously update the protocols online in response to new scientific developments, readers are encouraged to review the latest versions of the protocols.

  1. Klein, R., Klein, B.E., Moss, S.E., Cruickshanks, K.J. Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch. Intern. Med. 1994 Oct 10; 154(19): 2169-78.
  2. Raccah, D., Coste, T., Cameron, N.E., Dufayet, D., Vague, P., Hohman, T.C. Effect of the aldose reductase inhibitor tolrestat on nerve conduction velocity, Na/K ATPase activity, and polyols in red blood cells, sciatic nerve, kidney cortex, and kidney medulla of diabetic rats. J. Diabetes Complications 1998 May-Jun; 12(3): 154-62.
  3. Boehm, B.O., Lustig, R.H. Use of somatostatin receptor ligands in obesity and diabetic complications. Best Pract. Res. Clin. Gastroenterol. 2002 Jun; 16(3): 493-509.
  4. Leslie, R.D., Pozzilli, P. An introduction to new advances in diabetes. Diabetes Metab. Res. Rev. 2002 Jan-Feb; 18(Suppl. 1): S1-6.
  5. A. D. A. M.  Medical Encyclopedia. PubMed Health website. Retinopathy of prematurity. Available at: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002585/. May 4, 2011. Accessed October 15, 2012.
  6. Papp, A., Nemeth, I., Pelle, Z., Tekulics, P. Prospective biochemical study of the antioxidant defense capacity in retinopathy of premokemiai vizsgalata retinopathia preamaturorumban. Orv. Hetil. 1997 Jan 26; 138(4): 201-5.
  7. Guillausseau, P.J. Pharmacological prevention of diabetic microangiopathy. Diabete Metabol. 1994; 20(2 BIS): 219-28.
  8. Wang, A.M., Ma, C., Xie, Z.H., Shen, F. Use of carnosine as a natural anti-senescence drug for human beings. Biochemistry 2000 Jul; 65(7): 869-71.
  9. Beltramo E, Berrone E, Tarallo S, Porta M. Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications. Acta Diabetol. 2008 Sep;45(3):131-41.
  10. Stracke H, Hammes HP, Werkmann D, et al. Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats. Exp Clin Endocrinol Diabetes. 2001;109(6):330-6.
  11. Volvert ML, Seyen S, Piette M, et al. Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives. BMC Pharmacol. 2008 Jun 12;8:10.
  12. Balakumar P, Rohilla A, Krishan P, Solairaj P, Thangathirupathi A. The multifaceted therapeutic potential of benfotiamine. Pharmacol Res. 2010 Jun;61(6):482-8.
  13. Khatami M, Suldan Z, David I, Li W, Rockey JH. Inhibitory effects of pyridoxal phosphate, ascorbate and aminoguanidine on nonenzymatic glycosylation. Life Sci.1988;43(21):1725-31.
  14. Higuchi O, Nakagawa K, Tsuzuki T, Suzuki T, Oikawa S, Miyazawa T. Aminophospholipid glycation and its inhibitor screening system: a new role of pyridoxal 5’-phosphate as the inhibitor. J Lipid Res. 2006 May;47(5):964-74.
  15. Nakamura S, Niwa T. Pyridoxal phosphate and hepatocyte growth factor prevent dialysate-induced peritoneal damage. J Am Soc Nephrol. 2005 Jan;16(1):144-50.
  16. Nakamura S, Li H, Adijiang A, Pischetsrieder M, Niwa T. Pyridoxal phosphate prevents progression of diabetic nephropathy. Nephrol Dial Transplant. 2007Aug;22(8):2165-74.
  17. Niesman, M.R., Johnson, K.A., Penn, J.S. Therapeutic effect of liposomal superoxide dismutase in an animal model of retinopathy of prematurity. Neurochem. Res. 1997 May; 22(5): 597-605.
  18. Kowluru, R.A., Kern, T.S., Engerman, R.L. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system. Free Radic. Biol. Med. 1997; 22(4): 587-92.
  19. Mayer-Davis, E.J., Bell, R.A., Reboussin, B.A., Rushing, J., Marshall, J.A., Hamman, R.F. Antioxidant nutrient intake and diabetic retinopathy: The San Luis Valley Diabetes Study. Ophthalmology 1998 Dec; 105(12): 2264-70.
  20. Schalch, W. Carotenoids in the retina-a review of their possible role in preventing or limiting damage caused by light and oxygen. EXS 1992; 62: 280-98.
  21. Yeum, K.J., Shang, F.M., Schalch, W.M., Russell, R.M., Taylor, A. Fat-soluble nutrient concentrations in different layers of human cataractous lens. Curr. Eye Res. 1999 Dec; 19(6): 502-5.
  22. Siems, W.G., Sommerburg, O., van Kuijk, F.J. Lycopene and beta-carotene decompose more rapidly than lutein and zeaxanthin upon exposure to various pro-oxidants in vitro. Biofactors 1999; 10(2-3): 105-13.
  23. Rapp, L.M., Maple, S.S., Choi, J.H. Lutein and zeaxanthin concentrations in rod outer segment membranes from perifoveal and peripheral human retina. Invest. Ophthalmol. Vis. Sci. 2000 Apr; 41(5): 1200-9.
  24. Moeller, S.M., Jacques, P.F., Blumberg, J.B. The potential role of dietary xanthophylls in cataract and age-related macular degeneration. J. Am. Coll. Nutr. 2000 Oct; 19(5, Suppl.): 522S-527S.
  25. Bernstein, P.S., Khachik, F., Carvalho, L.S., Muir, G.J., Zhao, D.Y., Katz, N.B. Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye. Exp. Eye Res. 2001 Mar; 72(3): 215-23.
  26. Altomare, E., Grattagliano, I., Vendemaile, G., Micelli-Ferrari, T., Signorile, A., Cardia, L. Oxidative protein damage in human diabetic eye: evidence of a retinal participation. Eur. J. Clin. Invest. 1997 Feb; 27(2): 141-7.
  27. Anon. Vitamins for seeing. Compr. Ther. 1990; 16(4): 62.
  28. Chung, T.W., Yu, J.J., Liu, D.Z. Reducing lipid peroxidation stress of erythrocyte membrane by alpha-tocopherol nicotinate plays an important role in improving blood rheological properties in type 2 diabetic patients with retinopathy. Diabet. Med. 1998 May; 15(5): 380-5.
  29. Bursell, S.E., Clermont, A.C., Aiello, L.P., Aiello, L.M., Schlossman, D.K., Feener, E.P., Laffel, L., King, G.L. High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care 1999 Aug; 22(8): 1245-51.
  30. KaLuzny, J. Antioxidants for prophylaxis of eye diseases. Klin. Oczna 1996 Feb; 98(2): 141-3.
  31. Zigman, S., Rafferty, N.S., Rafferty, K.A., Lewis, N. Effects of green tea polyphenols on lens photooxidative stress. Biol. Bull. 1999 Oct; 197(2): 285-6.
  32. Thiagarajan, G., Chandani, S., Sundari, C.S., Rao, S.H., Kulkarni, A.V., Balasubramanian, D. Antioxidant properties of green and black tea, and their potential ability to retard the progression of eye lens cataract. Exp. Eye Res. 2001 Sep; 73(3): 393-401.
  33. Di Giulio, A.M., Lesma, E., Germani, E., Gorio, A. Inhibition of high glucose-induced protein mono-ADP-ribosylation restores neuritogenesis and sodium-pump activity in SY5Y neuroblastoma cells. J. Neurosci. Res. 1999 Sep 1; 57(5): 663-9.
  34. Gorio, A., Donadoni, M.L., Finco, C., Di Giulio, A.M. Endogenous mono-ADP-ribosylation in retina and peripheral nervous system. Effects of diabetes. Adv. Exp. Med. Biol. 1997; 419: 289-95.
  35. Hotta, N., Koh, N., Sakakibara, F., Nakamura, J., Hamada, Y., Hara, T., Fukasawa, H., Kakuta, H., Sakamoto, N. Effect of propionyl-L-carnitine on oscillatory potentials in electroretinogram in streptozotocin-diabetic rats. Eur. J. Pharmacol. 1996; 311(2-3): 199-206.